Chayasin Mansanguan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chayasin Mansanguan has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Prakaykaew Charunwatthana
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
4 shared publications Akkapon Poolcharoen
Bhumibol Adulyadej Hospital, Bangkok, Thailand
3 shared publicationsArun Huntrup
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
3 shared publicationsBorimas Hanboonkunupakarn
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
3 shared publicationsSant Muangnoicharoen
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
3 shared publicationsSuyanee Mansanguan
Bhumibol Adulyadej Hospital, Bangkok, Thailand
3 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (7) , 172
Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20–39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5–9.9 cm in diameter (43.4%), followed by 1–4.9 cm (42.1%) and ≥10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (χ2 = 63.56, p < 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen’s κ > 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- 24 June 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (7) , 172
Open AccessUltrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in the eastern city of Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: A total of 159 patients with liver hydatid cysts were included in the study. Among them, 91 (57.2%) were female, 80 (50.3%) were aged 20–39 years, and 128 (80.5%) resided in rural areas. Most patients presented with a single cyst (144/159, 90.6%), while multiple cysts were observed in 15 (9.4%). The majority of cysts measured 5–9.9 cm in diameter (43.4%), followed by 1–4.9 cm (42.1%) and ≥10 cm (14.5%). According to the WHO-IWGE classification, CE1 (25.8%) and CE4 (24.5%) were the most common stages, followed by CE2 (17.6%), CE3a (13.8%), CE3b (11.3%), and CE5 (7.0%). Common exposure-related factors included dog ownership, poor hygiene practices, and consumption of raw vegetables. Ultrasound accurately identified cyst stages and demonstrated a significant association between WHO-IWGE staging and treatment modality (χ2 = 63.56, p < 0.001). Almost perfect agreement was observed between ultrasound and CT for cyst classification (Cohen’s κ > 0.90), although CT provided additional anatomical information in selected complex cases. Conclusions: Ultrasound is an accessible, accurate, and reliable imaging modality for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- Open Access
- 26 May 2026
- Published by MDPI AG in Preprints.org
Ultrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in eastern city Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: Most patients were female (57.2%), aged 20–39 years, and from rural areas (80.5%). Common exposure-related factors included poor hygiene, dog ownership, and consumption of raw vegetables. Ultrasound effectively identified cyst stages and guided management decisions, with a significant association between WHO staging and treatment modality (χ² = 63.56, p < 0.001). There was almost perfect agreement between ultrasound and CT in cyst classification (Cohen’s κ > 0.9), although CT provided additional anatomical details in selected cases. Conclusion: Ultrasound is an accessible, accurate, and reliable tool for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- 26 May 2026
- Published by MDPI AG in Preprints.org
Open AccessUltrasound-Based Staging and Its Impact on Clinical Management of Hepatic Hydatid Cysts in an Endemic Setting: A Cross-Sectional Study in Eastern Afghanistan
Background: Hydatid disease, caused by Echinococcus granulosus, remains a significant public health concern in endemic regions. This study aimed to evaluate the role of ultrasound in the diagnosis, staging, and clinical management of liver hydatid cysts in eastern city Jalalabad, Afghanistan. Method: A cross-sectional study was conducted between February and November 2024 among 159 patients diagnosed with liver hydatid cysts. Demographic, clinical, laboratory, and imaging data were collected. Cysts were classified according to the WHO Informal Working Group on Echinococcosis (WHO-IWGE) and Gharbi systems. Ultrasound findings were compared with computed tomography (CT), and their association with treatment decisions was assessed. Result: Most patients were female (57.2%), aged 20–39 years, and from rural areas (80.5%). Common exposure-related factors included poor hygiene, dog ownership, and consumption of raw vegetables. Ultrasound effectively identified cyst stages and guided management decisions, with a significant association between WHO staging and treatment modality (χ² = 63.56, p < 0.001). There was almost perfect agreement between ultrasound and CT in cyst classification (Cohen’s κ > 0.9), although CT provided additional anatomical details in selected cases. Conclusion: Ultrasound is an accessible, accurate, and reliable tool for the diagnosis, staging, and management of liver hydatid cysts. In resource-limited settings, it serves as the primary imaging modality for guiding clinical decision-making, with CT reserved for complex or uncertain cases.
- Open Access
- 18 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26
Genetic characteristics and epidemiology of influenza and respiratory syncytial viruses associated with acute respiratory infections in Thailand
Influenza and respiratory syncytial virus (RSV) are significant contributors to acute respiratory infections and play a substantial role in seasonal morbidity. This study sought to elucidate the clinical characteristics, seasonal trends, and genetic evolution of circulating influenza and RSV strains in Thailand during the period from 2022 to 2023. Nasopharyngeal swabs were obtained from 113 patients presenting with respiratory symptoms. Laboratory confirmation identified 57 cases of influenza and 25 cases of RSV infections. Clinical and demographic data were subjected to analysis. The hemagglutinin (HA) and attachment glycoprotein (G) genes from representative strains of influenza and RSV viruses were sequenced to facilitate phylogenetic and amino acid analyses. Influenza cases were predominantly observed in younger adults aged 18–35 years, whereas RSV infections were distributed evenly across various age groups and were more prevalent among females. The clinical manifestations of influenza included cough, nasal congestion, sore throat, and myalgia. In contrast, RSV cases were associated with vomiting, pneumonia, bronchitis, and elevated rates of respiratory distress. The most prevalent influenza subtype was A/H3N2, accounting for 63.2% of cases, followed by A/H1N1 and B/Victoria. RSV-B was more prevalent than RSV-A, with a prevalence rate of 64.0%. The A/H3N2 strains exhibited divergence from the vaccine strain A/Darwin/9/2021, characterised by notable amino acid substitutions. Conversely, A/H1N1 strains remained closely aligned with the vaccine strains. The B/Victoria strains were categorised under the subclade V1A.3a.2 and consistently demonstrated a deletion of three amino acids in the HA gene. RSV-A isolates were identified as belonging to genotype ON1, while RSV-B isolates were classified under genotype BA9, both displaying characteristic duplications and substitutions. This study elucidates significant distinctions in the epidemiology and clinical outcomes of influenza and RSV in Thailand during 2022–2023. Influenza, particularly the A/H3N2 subtype, was more prevalent among younger adults and exhibited genetic divergence from the recommended vaccine strain, highlighting the necessity for continuous surveillance to inform vaccine updates. Conversely, RSV affected individuals across various age groups and was associated with more severe respiratory complications, with RSV-B being predominant. The genetic profiles of influenza and RSV strains, including amino acid substitutions and lineage-specific deletions or duplications, offer valuable insights into viral evolution and immune evasion. Collectively, these findings underscore the importance of integrated clinical and molecular surveillance to inform vaccine strain selection, enhance diagnostic accuracy, and bolster public health preparedness against seasonal respiratory pathogens. The online version contains supplementary material available at 10.1186/s12879-025-12355-7.
- 18 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26
Open AccessGenetic characteristics and epidemiology of influenza and respiratory syncytial viruses associated with acute respiratory infections in Thailand
Influenza and respiratory syncytial virus (RSV) are significant contributors to acute respiratory infections and play a substantial role in seasonal morbidity. This study sought to elucidate the clinical characteristics, seasonal trends, and genetic evolution of circulating influenza and RSV strains in Thailand during the period from 2022 to 2023. Nasopharyngeal swabs were obtained from 113 patients presenting with respiratory symptoms. Laboratory confirmation identified 57 cases of influenza and 25 cases of RSV infections. Clinical and demographic data were subjected to analysis. The hemagglutinin (HA) and attachment glycoprotein (G) genes from representative strains of influenza and RSV viruses were sequenced to facilitate phylogenetic and amino acid analyses. Influenza cases were predominantly observed in younger adults aged 18–35 years, whereas RSV infections were distributed evenly across various age groups and were more prevalent among females. The clinical manifestations of influenza included cough, nasal congestion, sore throat, and myalgia. In contrast, RSV cases were associated with vomiting, pneumonia, bronchitis, and elevated rates of respiratory distress. The most prevalent influenza subtype was A/H3N2, accounting for 63.2% of cases, followed by A/H1N1 and B/Victoria. RSV-B was more prevalent than RSV-A, with a prevalence rate of 64.0%. The A/H3N2 strains exhibited divergence from the vaccine strain A/Darwin/9/2021, characterised by notable amino acid substitutions. Conversely, A/H1N1 strains remained closely aligned with the vaccine strains. The B/Victoria strains were categorised under the subclade V1A.3a.2 and consistently demonstrated a deletion of three amino acids in the HA gene. RSV-A isolates were identified as belonging to genotype ON1, while RSV-B isolates were classified under genotype BA9, both displaying characteristic duplications and substitutions. This study elucidates significant distinctions in the epidemiology and clinical outcomes of influenza and RSV in Thailand during 2022–2023. Influenza, particularly the A/H3N2 subtype, was more prevalent among younger adults and exhibited genetic divergence from the recommended vaccine strain, highlighting the necessity for continuous surveillance to inform vaccine updates. Conversely, RSV affected individuals across various age groups and was associated with more severe respiratory complications, with RSV-B being predominant. The genetic profiles of influenza and RSV strains, including amino acid substitutions and lineage-specific deletions or duplications, offer valuable insights into viral evolution and immune evasion. Collectively, these findings underscore the importance of integrated clinical and molecular surveillance to inform vaccine strain selection, enhance diagnostic accuracy, and bolster public health preparedness against seasonal respiratory pathogens. The online version contains supplementary material available at 10.1186/s12879-025-12355-7.
- Open Access
- 31 October 2025
- Published by Springer Nature in Research Square
Outcomes of adult severe dengue in a tertiary care centre of Bangladesh: a cross-sectional retrospective observation
With an alarmingly high case fatality rate (CFR) of 0.56% in 2024, marking the consecutive year to report its devastating outbreak on record in 2023 with 1,705 fatalities, dengue fever presents a major public health challenge in Bangladesh, with seasonal outbreaks causing morbidity, mortality, and strain on the healthcare system. Understanding the factors influencing disease severity and outcomes is crucial for improving clinical management and reducing the disease burden. This retrospective observational study aimed to identify clinical patterns, risk factors, complications, and outcomes among adult severe dengue patients admitted to BIRDEM General Hospital, Dhaka, Bangladesh. Hospital records of admitted patients were analyzed to find the prevalence of severe dengue and explore the potential risk factors contributing to the severity of dengue outcomes. Key parameters included patient demographics, comorbidities, clinical manifestations, laboratory findings, and treatment outcomes. This retrospective study analyzed 330 adult dengue fever cases, identifying 26 (7.9%) as severe dengue. Severe dengue patients were significantly older (mean ~ 59 years), and showed a higher occurrence in pre-existing diabetes (84.6%), hypertension (69.2%), and chronic kidney disease (26.9%). Alteration of consciousness was significantly associated with severity, enhancing the odds of progressing to severe dengue by 51 times. Laboratory findings included significantly lower mean hematocrit (32.86%), hemoglobin (11.02 mg/dl), elevated liver enzymes (mean ALT 467.79 U/L, AST 865.3 U/L, ALP 146.41 U/L), lower serum albumin (31.7 mg/dL), elevated BUN (61.68 mg/dL), creatinine (2.71 mg/dL), and LDH (3007.33 U/L). A logistic regression model demonstrated good predictive ability (AUC = 0.8302), with alteration of consciousness and higher AST as independent risk factors of severe dengue. Based on the available data, despite high rates of complications (81% including plasma leakage, organ impairment, and concurrent co-infections), 16 (62%) were cured, and minimal mortality was reported (n = 3). By identifying high-risk populations and predictors of severe outcomes, this research aims to improve patient care and reduce dengue-related mortality.
- 31 October 2025
- Published by Springer Nature in Research Square
Open AccessOutcomes of adult severe dengue in a tertiary care centre of Bangladesh: a cross-sectional retrospective observation
With an alarmingly high case fatality rate (CFR) of 0.56% in 2024, marking the consecutive year to report its devastating outbreak on record in 2023 with 1,705 fatalities, dengue fever presents a major public health challenge in Bangladesh, with seasonal outbreaks causing morbidity, mortality, and strain on the healthcare system. Understanding the factors influencing disease severity and outcomes is crucial for improving clinical management and reducing the disease burden. This retrospective observational study aimed to identify clinical patterns, risk factors, complications, and outcomes among adult severe dengue patients admitted to BIRDEM General Hospital, Dhaka, Bangladesh. Hospital records of admitted patients were analyzed to find the prevalence of severe dengue and explore the potential risk factors contributing to the severity of dengue outcomes. Key parameters included patient demographics, comorbidities, clinical manifestations, laboratory findings, and treatment outcomes. This retrospective study analyzed 330 adult dengue fever cases, identifying 26 (7.9%) as severe dengue. Severe dengue patients were significantly older (mean ~ 59 years), and showed a higher occurrence in pre-existing diabetes (84.6%), hypertension (69.2%), and chronic kidney disease (26.9%). Alteration of consciousness was significantly associated with severity, enhancing the odds of progressing to severe dengue by 51 times. Laboratory findings included significantly lower mean hematocrit (32.86%), hemoglobin (11.02 mg/dl), elevated liver enzymes (mean ALT 467.79 U/L, AST 865.3 U/L, ALP 146.41 U/L), lower serum albumin (31.7 mg/dL), elevated BUN (61.68 mg/dL), creatinine (2.71 mg/dL), and LDH (3007.33 U/L). A logistic regression model demonstrated good predictive ability (AUC = 0.8302), with alteration of consciousness and higher AST as independent risk factors of severe dengue. Based on the available data, despite high rates of complications (81% including plasma leakage, organ impairment, and concurrent co-infections), 16 (62%) were cured, and minimal mortality was reported (n = 3). By identifying high-risk populations and predictors of severe outcomes, this research aims to improve patient care and reduce dengue-related mortality.
- Open Access
- 19 August 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (8) , 196
Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
This study focuses on cardiovascular manifestation, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students aged 13–18 years from two schools, who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography, and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms. We enrolled 314 participants; of these, 13 participants were lost to follow-up, leaving 301 participants for analysis. The most common cardiovascular signs and symptoms were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). One participant could have more than one sign and/or symptom. Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular manifestations were found in 29.24% of patients, ranging from tachycardia or palpitation to myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. In conclusion, Cardiovascular manifestation in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myopericarditis. The clinical presentation of myopericarditis after vaccination was usually mild and temporary, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for cardiovascular side effects. Clinical Trial Registration: NCT05288231.
- 19 August 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (8) , 196
Open AccessCardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
This study focuses on cardiovascular manifestation, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students aged 13–18 years from two schools, who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography, and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms. We enrolled 314 participants; of these, 13 participants were lost to follow-up, leaving 301 participants for analysis. The most common cardiovascular signs and symptoms were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). One participant could have more than one sign and/or symptom. Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular manifestations were found in 29.24% of patients, ranging from tachycardia or palpitation to myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. In conclusion, Cardiovascular manifestation in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myopericarditis. The clinical presentation of myopericarditis after vaccination was usually mild and temporary, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for cardiovascular side effects. Clinical Trial Registration: NCT05288231.
- Open Access
- 8 August 2022
- Published by MDPI AG in Preprints.org
Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms.We enrolled 314 participants; of these, 13 participants were lost to follow up, leaving 301 participants for analysis. The most common cardiovascular effects were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. Conclusion: Cardiovascular effects in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myocarditis. The clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects. Clinical Trial Registration: NCT05288231
- 8 August 2022
- Published by MDPI AG in Preprints.org
Open AccessCardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
This study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection in Thai adolescents. This prospective cohort study enrolled students from two schools aged 13–18 years who received the second dose of the BNT162b2 mRNA COVID-19 vaccine. Data including demographics, symptoms, vital signs, ECG, echocardiography and cardiac enzymes were collected at baseline, Day 3, Day 7, and Day 14 (optional) using case record forms.We enrolled 314 participants; of these, 13 participants were lost to follow up, leaving 301 participants for analysis. The most common cardiovascular effects were tachycardia (7.64%), shortness of breath (6.64%), palpitation (4.32%), chest pain (4.32%), and hypertension (3.99%). Seven participants (2.33%) exhibited at least one elevated cardiac biomarker or positive lab assessments. Cardiovascular effects were found in 29.24% of patients, ranging from tachycardia, palpitation, and myopericarditis. Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis and four patients had suspected subclinical myocarditis. Conclusion: Cardiovascular effects in adolescents after BNT162b2 mRNA COVID-19 vaccination included tachycardia, palpitation, and myocarditis. The clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects. Clinical Trial Registration: NCT05288231
- Open Access
- 10 September 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-13
Cardiac evaluation in adults with dengue virus infection by serial echocardiography
Background: Dengue virus infection (DVI) is a major health problem in many parts of the world. Its manifestations range from asymptomatic infections to severe disease. Although cardiac involvement has been reported in DVI, its incidence has not yet been well established. Methods: From July 2016 to January 2018, patients hospitalized at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand, with dengue virus infection confirmed by positive NS1 or positive dengue immunoglobulin M findings, participated in the study. We characterized the incidence and change in cardiac function by serial echocardiography and levels of troponin-T and creatine kinase-myocardial band (CK-MB) on the day of admission, the day of defervescence, the first day of hypotension (if any), and at 2 week follow-up. Results: Of the 81 patients evaluated, 6 (7.41%) exhibited elevated biomarker levels. There was no difference in clinical presentation amongst dengue fever, dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), except for the amount of bleeding. Cardiac involvement was found in 22.2% of patients: 3 (3.70%) had left ventricular systolic dysfunction, 3 (3.70%) had transient diastolic dysfunction, 6 (7.41%) had increased levels of at least one cardiac biomarker (troponin-T or CK-MB), and 6 (7.41%) had small pericardial effusion. Myocarditis was suspected in only two patients (with DHF); thus, myocarditis was uncommon in patients with dengue virus infection. Three patients developed DSS during admission and were transferred to the intensive care unit. Conclusion: Cardiac involvement in adults with dengue infection was common, ranging from elevated cardiac biomarker to myocarditis. Abnormalities in cardiac function had resolved spontaneously by the day of follow-up, without specific treatment. We found that DHF was a significant risk factor for cardiac involvement. Echocardiography is the investigation of choice for evaluating the haemodynamic status of patients with DVI, especially in severe dengue.
- 10 September 2021
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 21 (1) , 1-13
Open AccessCardiac evaluation in adults with dengue virus infection by serial echocardiography
Background: Dengue virus infection (DVI) is a major health problem in many parts of the world. Its manifestations range from asymptomatic infections to severe disease. Although cardiac involvement has been reported in DVI, its incidence has not yet been well established. Methods: From July 2016 to January 2018, patients hospitalized at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Thailand, with dengue virus infection confirmed by positive NS1 or positive dengue immunoglobulin M findings, participated in the study. We characterized the incidence and change in cardiac function by serial echocardiography and levels of troponin-T and creatine kinase-myocardial band (CK-MB) on the day of admission, the day of defervescence, the first day of hypotension (if any), and at 2 week follow-up. Results: Of the 81 patients evaluated, 6 (7.41%) exhibited elevated biomarker levels. There was no difference in clinical presentation amongst dengue fever, dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), except for the amount of bleeding. Cardiac involvement was found in 22.2% of patients: 3 (3.70%) had left ventricular systolic dysfunction, 3 (3.70%) had transient diastolic dysfunction, 6 (7.41%) had increased levels of at least one cardiac biomarker (troponin-T or CK-MB), and 6 (7.41%) had small pericardial effusion. Myocarditis was suspected in only two patients (with DHF); thus, myocarditis was uncommon in patients with dengue virus infection. Three patients developed DSS during admission and were transferred to the intensive care unit. Conclusion: Cardiac involvement in adults with dengue infection was common, ranging from elevated cardiac biomarker to myocarditis. Abnormalities in cardiac function had resolved spontaneously by the day of follow-up, without specific treatment. We found that DHF was a significant risk factor for cardiac involvement. Echocardiography is the investigation of choice for evaluating the haemodynamic status of patients with DVI, especially in severe dengue.
- Open Access
- 2 June 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (6) , 2009-2016
Etiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand
: Pneumonia is a leading cause of hospitalization and death among elderly adults. We performed a retrospective and prospective observational study to describe the etiology, clinical course, and outcomes of pneumonia for patients 60 years and older in Thailand. We enrolled 490 patients; 440 patients were included in the retrospective study and 50 patients were included in the prospective study. The CURB-65 score and a modified SMART-COP score (SMART-CO score) were used to assess disease severity. The median patient age was 80 years (interquartile range, 70–87 years); 51.2% were men. Klebsiella pneumoniae (20.4%) and Pseudomonas aeruginosa (15.5%) were the most common causative agents of pneumonia. A significant minority (23%) of patients were admitted to the intensive care unit (ICU), and mortality among this subset of patients was 45%. Most patients (80.8%) survived and were discharged from the hospital. The median duration of hospitalization was 8 days (interquartile range, 4–16 days). In contrast, 17.6% of patients died while undergoing care and 30-day mortality was 14%. Factors significantly associated with mortality were advanced age (P = 0.004), male sex (P = 0.005), multiple bacterial infections (P = 0.007; relative risk [RR], 1.88; 95% confidence interval [CI], 1.19–2.79), infection with multi-drug-resistant/extended-spectrum B-lactamase-producing organisms (P < 0.001; RR, 2.82; 95% CI, 1.83–4.85), ICU admission (P < 0.001; RR, 1.8; 95% CI, 1.4–2.3), and complications of pneumonia (P < 0.001; RR, 2.5; 95% CI, 1.8–3.4). Patients with higher SMART-CO and CURB-65 scores had higher rates of ICU admission and higher 30-day mortality rates (P < 0.001). These results emphasize the importance of Gram-negative bacteria, particularly K. pneumoniae and P. aeruginosa, as major causes of pneumonia among the elderly in contrast to other reports, Streptococcus pneumoniae is a common cause of pneumonia among elderly individuals worldwide. The SMART-COP and CURB-65 scores were developed to assess pneumonia severity and predict mortality of young adults with pneumonia. Few studies have examined the appropriateness of these scores for elderly patients with multiple comorbidities. A limited number of studies have used modified versions of these scores among elderly individuals. We found that Gram-negative bacteria has a major role in the etiology of pneumonia among elderly individuals in Southeast Asia. A significant proportion of elderly individuals with low CURB-65 scores were admitted to the hospital, indicating that hospital admission may reflect fragility among elderly individuals with low CURB-65 scores. The modified SMART-COP score (SMART-CO score) sufficiently predicted intensive care unit admission and the need for intensive vasopressor or respiratory support. A SMART-CO score ≥ 7 accurately predicted 30-day mortality.
- 2 June 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (6) , 2009-2016
Open AccessEtiology, Clinical Course, and Outcomes of Pneumonia in the Elderly: A Retrospective and Prospective Cohort Study in Thailand
: Pneumonia is a leading cause of hospitalization and death among elderly adults. We performed a retrospective and prospective observational study to describe the etiology, clinical course, and outcomes of pneumonia for patients 60 years and older in Thailand. We enrolled 490 patients; 440 patients were included in the retrospective study and 50 patients were included in the prospective study. The CURB-65 score and a modified SMART-COP score (SMART-CO score) were used to assess disease severity. The median patient age was 80 years (interquartile range, 70–87 years); 51.2% were men. Klebsiella pneumoniae (20.4%) and Pseudomonas aeruginosa (15.5%) were the most common causative agents of pneumonia. A significant minority (23%) of patients were admitted to the intensive care unit (ICU), and mortality among this subset of patients was 45%. Most patients (80.8%) survived and were discharged from the hospital. The median duration of hospitalization was 8 days (interquartile range, 4–16 days). In contrast, 17.6% of patients died while undergoing care and 30-day mortality was 14%. Factors significantly associated with mortality were advanced age (P = 0.004), male sex (P = 0.005), multiple bacterial infections (P = 0.007; relative risk [RR], 1.88; 95% confidence interval [CI], 1.19–2.79), infection with multi-drug-resistant/extended-spectrum B-lactamase-producing organisms (P < 0.001; RR, 2.82; 95% CI, 1.83–4.85), ICU admission (P < 0.001; RR, 1.8; 95% CI, 1.4–2.3), and complications of pneumonia (P < 0.001; RR, 2.5; 95% CI, 1.8–3.4). Patients with higher SMART-CO and CURB-65 scores had higher rates of ICU admission and higher 30-day mortality rates (P < 0.001). These results emphasize the importance of Gram-negative bacteria, particularly K. pneumoniae and P. aeruginosa, as major causes of pneumonia among the elderly in contrast to other reports, Streptococcus pneumoniae is a common cause of pneumonia among elderly individuals worldwide. The SMART-COP and CURB-65 scores were developed to assess pneumonia severity and predict mortality of young adults with pneumonia. Few studies have examined the appropriateness of these scores for elderly patients with multiple comorbidities. A limited number of studies have used modified versions of these scores among elderly individuals. We found that Gram-negative bacteria has a major role in the etiology of pneumonia among elderly individuals in Southeast Asia. A significant proportion of elderly individuals with low CURB-65 scores were admitted to the hospital, indicating that hospital admission may reflect fragility among elderly individuals with low CURB-65 scores. The modified SMART-COP score (SMART-CO score) sufficiently predicted intensive care unit admission and the need for intensive vasopressor or respiratory support. A SMART-CO score ≥ 7 accurately predicted 30-day mortality.
- Open Access
Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019
Influenza viruses continue to be a major public health threat due to the possible emergence of more virulent influenza virus strains resulting from dynamic changes in virus adaptability, consequent of functional mutations and antigenic drift in surface proteins, especially hemagglutinin (HA) and neuraminidase (NA). In this study, we describe the genetic and evolutionary characteristics of H1N1, H3N2, and influenza B strains detected in severe cases of seasonal influenza in Thailand from 2018 to 2019. We genetically characterized seven A/H1N1 isolates, seven A/H3N2 isolates, and six influenza B isolates. Five of the seven A/H1N1 viruses were found to belong to clade 6B.1 and were antigenically similar to A/Switzerland/3330/2017 (H1N1), whereas two isolates belonged to clade 6B.1A1 and clustered with A/Brisbane/02/2018 (H1N1). Interestingly, we observed additional mutations at antigenic sites (S91R, S181T, T202I) as well as a unique mutation at a receptor binding site (S200P). Three-dimensional (3D) protein structure analysis of hemagglutinin protein reveals that this unique mutation may lead to the altered binding of the HA protein to a sialic acid receptor. A/H3N2 isolates were found to belong to clade 3C.2a2 and 3C.2a1b, clustering with A/Switzerland/8060/2017 (H3N2) and A/South Australia/34/2019 (H3N2), respectively. Amino acid sequence analysis revealed 10 mutations at antigenic sites including T144A/I, T151K, Q213R, S214P, T176K, D69N, Q277R, N137K, N187K, and E78K/G. All influenza B isolates in this study belong to the Victoria lineage. Five out of six isolates belong to clade 1A3-DEL, which relate closely to B/Washington/02/2009, with one isolate lacking the three amino acid deletion on the HA segment at position K162, N163, and D164. In comparison to the B/Colorado/06/2017, which is the representative of influenza B Victoria lineage vaccine strain, these substitutions include G129D, G133R, K136E, and V180R for HA protein. Importantly, the susceptibility to oseltamivir of influenza B isolates, but not A/H1N1 and A/H3N2 isolates, were reduced as assessed by the phenotypic assay. This study demonstrates the importance of monitoring genetic variation in influenza viruses regarding how acquired mutations could be associated with an improved adaptability for efficient transmission.
Open AccessMolecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018–2019
Influenza viruses continue to be a major public health threat due to the possible emergence of more virulent influenza virus strains resulting from dynamic changes in virus adaptability, consequent of functional mutations and antigenic drift in surface proteins, especially hemagglutinin (HA) and neuraminidase (NA). In this study, we describe the genetic and evolutionary characteristics of H1N1, H3N2, and influenza B strains detected in severe cases of seasonal influenza in Thailand from 2018 to 2019. We genetically characterized seven A/H1N1 isolates, seven A/H3N2 isolates, and six influenza B isolates. Five of the seven A/H1N1 viruses were found to belong to clade 6B.1 and were antigenically similar to A/Switzerland/3330/2017 (H1N1), whereas two isolates belonged to clade 6B.1A1 and clustered with A/Brisbane/02/2018 (H1N1). Interestingly, we observed additional mutations at antigenic sites (S91R, S181T, T202I) as well as a unique mutation at a receptor binding site (S200P). Three-dimensional (3D) protein structure analysis of hemagglutinin protein reveals that this unique mutation may lead to the altered binding of the HA protein to a sialic acid receptor. A/H3N2 isolates were found to belong to clade 3C.2a2 and 3C.2a1b, clustering with A/Switzerland/8060/2017 (H3N2) and A/South Australia/34/2019 (H3N2), respectively. Amino acid sequence analysis revealed 10 mutations at antigenic sites including T144A/I, T151K, Q213R, S214P, T176K, D69N, Q277R, N137K, N187K, and E78K/G. All influenza B isolates in this study belong to the Victoria lineage. Five out of six isolates belong to clade 1A3-DEL, which relate closely to B/Washington/02/2009, with one isolate lacking the three amino acid deletion on the HA segment at position K162, N163, and D164. In comparison to the B/Colorado/06/2017, which is the representative of influenza B Victoria lineage vaccine strain, these substitutions include G129D, G133R, K136E, and V180R for HA protein. Importantly, the susceptibility to oseltamivir of influenza B isolates, but not A/H1N1 and A/H3N2 isolates, were reduced as assessed by the phenotypic assay. This study demonstrates the importance of monitoring genetic variation in influenza viruses regarding how acquired mutations could be associated with an improved adaptability for efficient transmission.
- Open Access
- 2 February 2021
- Published by Wiley in International Journal of Dentistry
- Vol. 2021, 1-10
Periodontal Treatment Improves Serum Levels of Leptin, Adiponectin, and C-Reactive Protein in Thai Patients with Overweight or Obesity
Periodontitis and overweight or obesity independently change serum levels of leptin, adiponectin, and C-reactive protein (CRP). The aim of this study is to investigate the alterations of serum levels of leptin, adiponectin, and CRP after nonsurgical periodontal treatment (NSPT) in Thai patients with overweight or obesity (Owt/Ob) who did or did not exhibit severe periodontitis (SP) and normal weight (Nwt) patients with or without SP. Two hundred sixty patients were screened; 29 patients were included in this study. The study participants comprised 6 patients with Owt/Ob who exhibited SP, 11 patients with Owt/Ob who did not exhibit SP, 5 Nwt patients with SP, and 7 Nwt patients without SP. Periodontal disease status was evaluated; serum levels of leptin, adiponectin, and CRP were determined by enzyme-linked immunosorbent assay at baseline, as well as at 3 and 6 months after NSPT. At 3 months after NSPT, periodontal status was improved in all groups ( < 0.05), except Nwt patients without SP. Serum levels of leptin and CRP were significantly reduced, while serum levels of adiponectin were elevated after NSPT, regardless of bodyweight or waist circumference ( < 0.05). Improvement in serum levels of leptin after NSPT was also observed in the Nwt with SP group ( = 0.015); these levels did not significantly differ in Nwt patients without SP. NSPT reduces serum levels of leptin and CRP and enhances serum levels of adiponectin in Thai patients with Owt/Ob, irrespective of periodontitis severity. These results suggest a role for periodontal treatment in the systemic inflammatory response of Thai people with Owt/Ob.
- 2 February 2021
- Published by Wiley in International Journal of Dentistry
- Vol. 2021, 1-10
Open AccessPeriodontal Treatment Improves Serum Levels of Leptin, Adiponectin, and C-Reactive Protein in Thai Patients with Overweight or Obesity
Periodontitis and overweight or obesity independently change serum levels of leptin, adiponectin, and C-reactive protein (CRP). The aim of this study is to investigate the alterations of serum levels of leptin, adiponectin, and CRP after nonsurgical periodontal treatment (NSPT) in Thai patients with overweight or obesity (Owt/Ob) who did or did not exhibit severe periodontitis (SP) and normal weight (Nwt) patients with or without SP. Two hundred sixty patients were screened; 29 patients were included in this study. The study participants comprised 6 patients with Owt/Ob who exhibited SP, 11 patients with Owt/Ob who did not exhibit SP, 5 Nwt patients with SP, and 7 Nwt patients without SP. Periodontal disease status was evaluated; serum levels of leptin, adiponectin, and CRP were determined by enzyme-linked immunosorbent assay at baseline, as well as at 3 and 6 months after NSPT. At 3 months after NSPT, periodontal status was improved in all groups ( < 0.05), except Nwt patients without SP. Serum levels of leptin and CRP were significantly reduced, while serum levels of adiponectin were elevated after NSPT, regardless of bodyweight or waist circumference ( < 0.05). Improvement in serum levels of leptin after NSPT was also observed in the Nwt with SP group ( = 0.015); these levels did not significantly differ in Nwt patients without SP. NSPT reduces serum levels of leptin and CRP and enhances serum levels of adiponectin in Thai patients with Owt/Ob, irrespective of periodontitis severity. These results suggest a role for periodontal treatment in the systemic inflammatory response of Thai people with Owt/Ob.